10-propargyl-10-deazaaminopterin has been researched along with Thrombopenia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gumbs, AA; MacGregor-Cortelli, B; Neylon, E; O'Connor, OA; Patterson, M; Zain, J | 1 |
| Bartlett, NL; Delioukina, ML; Duvic, M; Fisher, DC; Foss, F; Horwitz, SM; Kim, YH; Koutsoukos, T; Lechowicz, MJ; Myskowski, PL; O'Connor, OA; Saunders, ME; Shustov, AR; Zain, JM | 1 |
1 trial(s) available for 10-propargyl-10-deazaaminopterin and Thrombopenia
| Article | Year |
|---|---|
Identification of an active, well-tolerated dose of pralatrexate in patients with relapsed or refractory cutaneous T-cell lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Aminopterin; Antimetabolites, Antineoplastic; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Eruptions; Fatigue; Female; Gastrointestinal Diseases; Humans; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Mucositis; Neutropenia; Salvage Therapy; Skin Neoplasms; Thrombocytopenia | 2012 |
1 other study(ies) available for 10-propargyl-10-deazaaminopterin and Thrombopenia
| Article | Year |
|---|---|
Importance of early splenectomy in patients with hepatosplenic T-cell lymphoma and severe thrombocytopenia.
Topics: Aminopterin; Fatal Outcome; Hematologic Agents; Humans; Laparoscopy; Liver Neoplasms; Lymphoma, T-Cell; Male; Middle Aged; Splenectomy; Splenic Neoplasms; Thrombocytopenia; Treatment Outcome; Young Adult | 2009 |